• Agenda
  • Initiatives
  • Reports
  • Events
  • About
    • Our Mission
    • Leadership and Governance
    • Our Members and Partners
    • Communities
    • History
    • Klaus Schwab
    • Media
    • Contact Us
    • Careers
    • World Economic Forum USA
    • Privacy and Terms of Use
  • EN ES FR 日本語 中文
  • Login to TopLink

We use cookies to improve your experience on our website. By using our website you consent to all cookies in accordance with our updated Cookie Notice.

I accept
    Hamburger
  • World Economic Forum Logo
  • Agenda
  • Initiatives
  • Reports
  • Events
  • About
  • TopLink
  • Search Cancel

Report Home

<Previous Next>
  • Foreword
  • Index
  • Introduction
  • Company Profiles
    • Adtelligence GmbH
    • Advantix Systems
    • Agios Pharmaceuticals Inc.
    • Airbnb
    • Alphabet Energy Inc.
    • AppNexus Inc.
    • BIND Therapeutics Inc.
    • bluebird bio
    • Bug Agentes Biológicos
    • Codecademy
    • Coursera Inc.
    • Cyberdyne Inc.
    • D-Rev: Design Revolution
    • Data4
    • Dnevnik.ru
    • EcoNation
    • Foundation Medicine Inc.
    • GitHub
    • Jana
    • Kaggle Inc.
    • Kebony AS
    • Koemei SA
    • Lenddo
    • LiveU Ltd
    • Natera
    • Nest Labs Inc.
    • Oasys Water Inc.
    • OMC Power
    • Rethink Robotics
    • Second Sight Medical Products Inc.
    • Selecta Biosciences Inc.
    • SunPartner
    • SynTouch LLC
    • TruTag Technologies Inc.
    • Viki Inc.
    • WiTricity Corporation
  • Selection Committee 2014
  • Acknowledgements
Technology Pioneers 2014 Home Previous Next
  • Report Home
  • Foreword
  • Index
  • Introduction
  • Company Profiles

    • Adtelligence GmbH
    • Advantix Systems
    • Agios Pharmaceuticals Inc.
    • Airbnb
    • Alphabet Energy Inc.
    • AppNexus Inc.
    • BIND Therapeutics Inc.
    • bluebird bio
    • Bug Agentes Biológicos
    • Codecademy
    • Coursera Inc.
    • Cyberdyne Inc.
    • D-Rev: Design Revolution
    • Data4
    • Dnevnik.ru
    • EcoNation
    • Foundation Medicine Inc.
    • GitHub
    • Jana
    • Kaggle Inc.
    • Kebony AS
    • Koemei SA
    • Lenddo
    • LiveU Ltd
    • Natera
    • Nest Labs Inc.
    • Oasys Water Inc.
    • OMC Power
    • Rethink Robotics
    • Second Sight Medical Products Inc.
    • Selecta Biosciences Inc.
    • SunPartner
    • SynTouch LLC
    • TruTag Technologies Inc.
    • Viki Inc.
    • WiTricity Corporation
  • Selection Committee 2014
  • Acknowledgements

Second Sight Medical Products Inc.

IMG031C_WR031_SECOND-SIGHT-I

Second Sight Medical Products Inc.

Video: Technology Pioneer 2014⎪Robert Greenberg⎪Second Sight

Robert Greenberg,
President and Chief Executive Officer

Location: California, USA
Number of employees: 88
Year founded: 1998

Second Sight Medical Products Inc.
12744 San Fernando Road, Building 3
Sylmar, CA 91342
USA 

Website: www.2-sight.com

Second Sight has developed the first ever approved treatment to partially restore vision to blind people. The Argus II Retinal Prosthesis System is enabling some blind patients to perform visual tasks such as identifying doorways, following sidewalks and reading large-print words.

In a healthy eye, cells in the retina called photoreceptors convert light into electrochemical impulses that are sent to the brain, which processes them into images. Diseases such as retinitis pigmentosa cause blindness due to the death of those photoreceptors.

The Argus II involves an implant which is surgically inserted onto the retina. The patient wears glasses containing a camera; a small computer, worn on a belt, processes signals from the camera, and an antenna on the side of the glasses transmits them wirelessly to the implant. The implant sends electrical impulses to the brain, causing the patient to perceive patterns of light.

The system is not an exact replacement for natural vision, as patients often need to learn to interpret these patterns of light, and rates of progress vary. Second Sight is using feedback from patients to refine aspects of the image processing software, and is also working on enhancing image resolution by developing implants with more electrodes.

The Argus II is currently available in eight countries to treat blindness caused by conditions related to retinal degeneration. It could potentially also be used to treat macular degeneration. For the longer term, Second Sight is working on a cortical implant, which would enable nearly all causes of blindness to be treated.

Back to Top
Subscribe for updates
A weekly update of what’s on the Global Agenda
Follow Us
About
Our Mission
Leadership and Governance
Our Members and Partners
The Fourth Industrial Revolution
Centre for the Fourth Industrial Revolution
Communities
History
Klaus Schwab
Our Impact
Media
Pictures
A Global Platform for Geostrategic Collaboration
Careers
Open Forum
Contact Us
Mapping Global Transformations
Code of Conduct
World Economic Forum LLC
Sustainability
World Economic Forum Privacy Policy
Media
News
Accreditation
Subscribe to our news
Members & Partners
Member login to TopLink
Strategic Partners' area
Partner Institutes' area
Global sites
Centre for the Fourth Industrial Revolution
Open Forum
Global Shapers
Schwab Foundation for Social Entrepreneurship
EN ES FR 日本語 中文
© 2022 World Economic Forum
Privacy Policy & Terms of Service